New way to short Tesla with AXS Investments ETF

Investors have a new way to make bullish and bearish bets on large-cap stocks. AXS Investments launched eight of 18 approved single-stock leveraged ETFs this month. The funds aim to increase exposure ...

25 Stocks That Could Rise on a Short Squeeze

Investors betting against electric-vehicle stocks take note: Five of 25 stocks that short-selling research firm S3 Partners identified this month as being at risk of a short squeeze are in the EV busi...

Buying stocks now could bring you pain over the next few weeks. But you’ll be thanking yourself a year from now, these analysts say.

How bad is the mood out there right now? Try max bearish. So said Bank of America’s latest fund manager survey on Tuesday that showed expectations for profits and growth at recessionary levels. Yet Wa...

GSK Spins Off $36 Billion Consumer-Healthcare Business Haleon

GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new stand-alo...

UnitedHealth to Drop Copays on Some Widely Used Drugs

UnitedHealth Group Inc. said it would eliminate copayments and other out-of-pocket charges for patients on some widely used drugs in certain plans next year, including insulin and the anti-overdose tr...

Endo Moving Toward Bankruptcy Filing Without Opioid Settlement Deal

Endo International PLC is moving toward a bankruptcy filing, potentially setting off intense conflicts with state and local governments that have sued the pharmaceuticals company for its alleged role ...

WHO to decide if monkeypox is a global health threat next week

Health officer uses a thermal head to detect a monkeypox virus on arriving passengers at Soekarno-Hatta International Airport in Tangerang near Jakarta, Indonesia on May 15, 2019. Jepayona Delita | Fu...

This strategist warned investors not to chase momentum at the top. Now he says it’s time to be a contrarian.

Michael Darda, chief economist and market strategist at MKM Partners, was no fan of the stock market when it was registering record highs. “Blinded by liquidity and false expectations of the proverbia...

Seagen Stock Leaps On Report Of $40 Billion Takeover By Merck

Seagen  (SGEN) – Get Seagen Inc. Report shares powered higher Thursday following a report from the Wall Street Journal that it’s in advanced takeover talks with drugmaker Merck & Co.  ...

Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion

Text size New Jersey-based Merck has a market value of more than $234 billion. Michael Vi/Dreamstime Merck & Co  is in advanced talks to buy Seagen in a deal that could value the cancer biotech at...

Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More

Merck & Co. is in advanced talks to acquire Seagen and is aiming to agree on a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal that co...

Boeing and 7 More Industrial Stocks for the Second Half of 2022

Text size Industrial demand held up better than industrial stocks in the second quarter. Dreamstime The first half of 2022 was lousy for most stocks, including shares in the industrial sector. But tha...

Pfizer Raises Covid-19 Vaccine Price 27%. What It Means for the Stock.

Text size Pfizer said it has signed a deal to supply the U.S. with vaccines in the fall, while Moderna has yet to announce a sale. Jacob King – WPA Pool / Getty Images Pfizer has raised the U.S....

Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan

Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas N...

Axsome Therapeutics Stock Soars on Proposed FDA Labeling for Depression Drug

Text size Axsome is reviewing the proposed labeling from the FDA. Dreamstime Shares of Axsome Therapeutics were soaring Monday after the biopharmaceutical company announced some good news in an attemp...

Merck Pushes Forward With Potential Deal for Seagen

Merck & Co. is pushing forward with a potential deal for biotech Seagen Inc., according to people familiar with the matter, in what would be one of the largest takeovers of the year. The Wall Stre...

This dividend fund is down 3% vs. S&P’s 20% drop. Here are its top stock picks

By now even the most ardent tech and growth-stock enthusiasts realize the bull market is over. John Kornitzer’s approach to selecting high-quality stocks for the Buffalo Flexible Income Fund is one th...

Buying From Mark Cuban’s Pharmacy Could Save Medicare Billions, Study Says

Medicare’s prescription-drug program could save billions of dollars annually if it purchased generic acid-reflux, cancer and other drugs from a new pharmacy backed by investor Mark Cuban, according to...

FedEx’s Dividend Hike Stands Out

Text size FedEx trucks at a sorting facility Justin Sullivan/Getty Images FedEx grabbed the headlines this week for dividend announcements, declaring an increase of more than 50% to its quarterly payo...

The Days of Big Pharma Are Over. Big Biotech Is on Its Way.

W hen GlaxoSmithKline spins off its enormous division selling drugstore staples like Advil and Tums next month, it will represent more than just the latest shuffling of assets among corporate giants. ...

Roku, Tesla, and Other Cathie Wood Favorites Are Falling

Text size Ark Invest CEO Cathie Wood. Courtesy of ARK Cathie Wood’s $12 billion flagship exchange-traded fund was falling again in Monday trading. It is another sign that “innovation stocks” such as R...

Five Beaten-Up Biotech Stocks Saw Big Share Purchases

Text size Biotech stocks Kymera, Cullinan Oncology, Repare, Iovance, and Kodiak Sciences are all in the red so far this year, but they’ve seen large stock buys. Dreamstime Biotech stocks have taken so...

Novavax’s New Covid-19 Vaccine Might Be Late to the Party

It’s one thing to arrive fashionably late to a party, it’s another thing to waltz in when the last guests are stumbling out the door. For Novavax , which on Tuesday cleared a key step toward U.S. Food...

Yellen Says Inflation Is Here to Stay While Target Is Cutting Prices. They’re Not at Odds.

At the same time, Target said on Tuesday it will have to cut prices to shift inventory, further hurting profitability this year. That seems like a contradiction. But it makes sense if we accept that f...

Top 10 Stocks by Searches; One Guess Which is No. 1

The most popular stocks in the United States could be measured in a lot of ways.  One brokerage recently opted to use frequency of search to come up with a list.  XTB Online Trading screened out the 5...

AMD, Pfizer, NIO, DocuSign, Campbell Soup, and Other Stocks for Investors to Watch This Week

It’s a relatively quiet week on the earnings calendar. Highlights will include J.M. Smucker on Tuesday, Campbell Soup on Wednesday, and DocuSign, NIO, and Vail Resorts on Thursday. Pfizer also hosts a...

Tonix Pharmaceuticals jumps 25%, and here is why

Tonix Pharmaceuticals Corp (NASDAQ: TNXP) was up 25% after announcing that the US Patent and Trademark Office gave it a US Patent No. 11,342,896 on May 31, 2022. The patent is titled “Synthetic Chimer...

Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.

Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...

Hot stocks may bring an initial thrill, but they’ll break your heart

My father was born ​in 1936 in Brooklyn. He attended Erasmus High School, earned a degree in chemical engineering from Brooklyn Polytechnic High School and then went on to study dentistry at New York ...

Monkeypox cases are driving up stock prices for these companies

Growing concern about the emergence of monkeypox in Europe and the U.S. has sent shares of several vaccine and drug companies soaring. Though infections are rarely reported outside of Central and West...

Novavax Gets a Sell Rating. It’s Got a Covid Vaccine Problem, Analyst Says.

Text size A healthcare worker prepares a dose of Nuvaxovid vaccine. Jeroen Jumelet/ANP/AFP via Getty Images Novavax stock was dropping Friday after receiving a Sell-equivalent rating — the first since...

Martin Shkreli released from federal prison into halfway house

Former pharmaceutical executive Martin Shkreli departs the U.S. District Court for the Eastern District of New York, August 3, 2017 in the Brooklyn borough of New York City. Getty Images Notorious ...